BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37348172)

  • 1. Ruthenium(II) complexes as mitochondrial inhibitors of topoisomerase induced A549 cell apoptosis.
    Tang H; Guo X; Yu W; Gao J; Zhu X; Huang Z; Ou W; Zhang H; Chen L; Chen J
    J Inorg Biochem; 2023 Sep; 246():112295. PubMed ID: 37348172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
    Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
    Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes.
    Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y
    Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Hydroxyquinoline-modified ruthenium(II) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy.
    Ma X; Lu J; Yang P; Zhang Z; Huang B; Li R; Ye R
    Dalton Trans; 2022 Sep; 51(36):13902-13909. PubMed ID: 36040403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
    Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
    J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, RNA-sequence and evaluation of anticancer efficacy of ruthenium(II) polypyridyl complexes toward HepG2 cells.
    Hu H; Zhang H; Zhong R; Yang Y; Huang C; Chen J; Liang L; Chen Y; Liu Y
    J Inorg Biochem; 2023 Jul; 244():112230. PubMed ID: 37084581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
    Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
    Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance.
    Wei L; He X; Zhao D; Kandawa-Shultz M; Shao G; Wang Y
    Eur J Med Chem; 2024 Jan; 264():115985. PubMed ID: 38016298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
    Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
    Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.
    Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T
    Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion.
    Xie L; Wang L; Guan R; Ji L; Chao H
    J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest.
    Li YL; Zhu XM; Chen NF; Chen ST; Yang Y; Liang H; Chen ZF
    Eur J Med Chem; 2022 Jun; 236():114312. PubMed ID: 35421660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts.
    Mandal AA; Singh V; Saha S; Peters S; Sadhukhan T; Kushwaha R; Yadav AK; Mandal A; Upadhyay A; Bera A; Dutta A; Koch B; Banerjee S
    Inorg Chem; 2024 Apr; 63(16):7493-7503. PubMed ID: 38578920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: Playing with auxiliary ligands for tuning the mechanism of biological activity.
    Łomzik M; Mazuryk O; Rutkowska-Zbik D; Stochel G; Gros PC; Brindell M
    J Inorg Biochem; 2017 Oct; 175():80-91. PubMed ID: 28738277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclometalated Ru(II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling.
    Chen J; Deng Y; Wang J; Chen S; Peng F; He X; Liu M; Luo H; Zhang J; Chen L
    J Biol Inorg Chem; 2021 Oct; 26(7):793-808. PubMed ID: 34459988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
    Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
    J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.